Total Debt
$31.6M
Net Debt
-$610.5M
Relay Therapeutics, Inc. currently has $31.6M in total debt. Net debt is -$610.5M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
RLAY • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.03 | 0.64 | -0.61Net Cash | 0.70 | 4.5% |
| 2025-12-31 | 0.03 | 0.55 | -0.52Net Cash | 0.62 | 5.2% |
| 2025-09-30 | 0.03 | 0.60 | -0.56Net Cash | 0.67 | 5.0% |
| 2025-06-30 | 0.03 | 0.66 | -0.62Net Cash | 0.73 | 4.7% |
| 2025-03-31 | 0.05 | 0.71 | -0.66Net Cash | 0.80 | 5.9% |
| 2024-12-31 | 0.05 | 0.78 | -0.73Net Cash | 0.87 | 5.6% |
| 2024-09-30 | 0.05 | 0.84 | -0.79Net Cash | 0.93 | 5.4% |
| 2024-06-30 | 0.05 | 0.69 | -0.64Net Cash | 0.77 | 6.6% |
| 2024-03-31 | 0.05 | 0.75 | -0.70Net Cash | 0.84 | 6.2% |
| 2023-12-31 | 0.05 | 0.75 | -0.70Net Cash | 0.84 | 6.3% |
| 2023-09-30 | 0.05 | 0.81 | -0.76Net Cash | 0.91 | 6.0% |
| 2023-06-30 | 0.06 | 0.87 | -0.82Net Cash | 0.96 | 5.8% |
| 2023-03-31 | 0.06 | 0.94 | -0.88Net Cash | 1.04 | 5.5% |
| 2022-12-31 | 0.06 | 1.00 | -0.94Net Cash | 1.10 | 5.3% |
| 2022-09-30 | 0.06 | 1.05 | -0.99Net Cash | 1.17 | 5.2% |
| 2022-06-30 | 0.02 | 0.84 | -0.82Net Cash | 0.89 | 2.5% |
| 2022-03-31 | 0.02 | 0.90 | -0.88Net Cash | 0.95 | 2.4% |
| 2021-12-31 | 0.02 | 0.96 | -0.94Net Cash | 1.01 | 2.3% |
| 2021-09-30 | 0.02 | 0.62 | -0.59Net Cash | 0.67 | 3.5% |
| 2021-06-30 | 0.02 | 0.67 | -0.65Net Cash | 0.71 | 3.3% |
| 2021-03-31 | 0.02 | 0.73 | -0.70Net Cash | 0.77 | 3.1% |
| 2020-12-31 | 0.02 | 0.68 | -0.65Net Cash | 0.80 | 3.1% |
| 2020-09-30 | 0.02 | 0.71 | -0.69Net Cash | 0.75 | 3.2% |
| 2020-06-30 | 0.02 | 0.31 | -0.29Net Cash | 0.35 | 7.0% |
| 2020-03-31 | 0.02 | 0.33 | -0.31Net Cash | 0.37 | 6.6% |
| 2019-12-31 | 0.02 | 0.36 | -0.33Net Cash | 0.39 | 6.3% |
| 2019-03-31 | 0.00 | 0.42 | -0.42Net Cash | 0.00 | — |